AI Analysis AI Analysis of HBIO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HBIO to Watchlist?
Some Reasons Why To Add HBIO:
  • Bullish trend confirmed on both short and long timeframes
  • Solid financial health (Piotroski 5/9)
  • Trading above its 200-day moving average
PDF

Harvard Bioscience stock upgraded from Hold/Accumulate to Buy Candidate after Thursday trading session
(Updated on Jul 02, 2026)

Buy or Hold candidate since Jun 30, 2026

The Harvard Bioscience stock price gained 1.65% on the last trading day (Thursday, 2nd Jul 2026), rising from $6.05 to $6.15. During the last trading day the stock fluctuated 5.05% from a day low at $5.94 to a day high of $6.24. The price has risen in 6 of the last 10 days and is up by 2.5% over the past 2 weeks. Volume fell on the last day by -11 thousand shares and in total, 9 thousand shares were bought and sold for approximately $56.30 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.59% during the next 3 months and, with a 90% probability hold a price between $4.71 and $7.67 at the end of this 3-month period.

HBIO Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, June 11, 2026, and so far it has fallen -7.38%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. The Harvard Bioscience stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $6.08 and $5.93. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Harvard Bioscience stock

Harvard Bioscience finds support from accumulated volume at $5.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.300 between high and low, or 5.05%. For the last week the stock has had daily average volatility of 4.38%.

Our recommended stop-loss: $5.86 (-4.67%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (HBIO) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Harvard Bioscience to open at $6.11, and during the day (based on 14 day Average True Range), to move between $5.98 and $6.32, which gives a possible trading interval of +/-$0.347 (+/-5.80%) up or down from last closing price. If Harvard Bioscience takes out the full calculated possible swing range there will be an estimated 5.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.95 (3.25%) than the resistance at $6.40 (4.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Harvard Bioscience stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Harvard Bioscience stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.034 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $6.11 ( 0.651%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HBIO Performance

Trading levels for HBIO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.41 4.23%
R2 6.30 2.36%
R1 6.22 1.21%
Price 6.15
S1 6.00 -2.51%
S2 5.92 -3.66%
S3 5.81 -5.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 7.24 17.72%
R2 6.99 13.66%
R1 6.40 4.07%
Price 6.15
S1 5.95 -3.25%
S2 5.74 -6.67%
S3 4.66 -24.31%

FAQ

What is the symbol for Harvard Bioscience Stock and on which exchange is it traded?
The symbol for Harvard Bioscience is HBIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Harvard Bioscience Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Harvard Bioscience stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Harvard Bioscience Stock?
Harvard Bioscience Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Harvard Bioscience Stock.

What's the current price of Harvard Bioscience Stock?
As of the end of day on the Jul 02, 2026, the price of an Harvard Bioscience (HBIO) share was $6.15.

What is the 52-week high and low for Harvard Bioscience Stock?
The 52-week high for Harvard Bioscience Stock is $9.40 and the 52-week low is $3.78.

What is the market capitalization of Harvard Bioscience Stock?
As of the Jul 02, 2026, the market capitalization of Harvard Bioscience is 27.738M.

When is the next earnings date for Harvard Bioscience?
The upcoming earnings date for Harvard Bioscience is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT HARVARD BIOSCIENCE
Harvard Bioscience
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgic...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE